Emma Blaney
Chief Operating Officer at C4X DISCOVERY HOLDINGS PLC
Network origin in Emma Blaney first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Emma Blaney via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Founder | |
Lehman Brothers Holdings Plc
 Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK. | Investment Banks/Brokers | Corporate Officer/Principal | |
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Modern Biosciences Ltd.
 Modern Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Istesso Ltd., Modern Biosciences Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in London, UK. The company was founded by Samuel Cameron Williams, Alexander James Stevenson. Samuel Cameron Williams has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman Founder Founder | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| OXFORD BIOMEDICA PLC | Biotechnology | Public Communications Contact | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| IP GROUP PLC | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree Doctorate Degree | |
| University of Leeds | College/University | Doctorate Degree | |
Pharminox Ltd
 Pharminox Ltd Medical/Nursing ServicesHealth Services Pharminox Ltd develops treatments for cancer therapy. The private company is based in Abingdon, UK. The British company was founded by Neil L. Brown. | Medical/Nursing Services | Chairman Director/Board Member | |
| University of Birmingham | College/University | Doctorate Degree Doctorate Degree | |
RSA Consulting Ltd.
 RSA Consulting Ltd. Personnel ServicesCommercial Services RSA Consulting Ltd. provides recruitment services. It also provides services like business planning, process realignment, user requirement specification, systems implementation, and market entry. The company was founded in 1981 and is headquartered in Hatfield, the United Kingdom. | Personnel Services | Director/Board Member | |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
| University of Surrey | College/University | Undergraduate Degree | |
| AVACTA GROUP PLC | Miscellaneous Commercial Services | President Director/Board Member | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
| DIUL GROUP | Pharmaceuticals: Major | Chairman | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
GT Biologics Ltd.
 GT Biologics Ltd. Pharmaceuticals: MajorHealth Technology GT Biologics Ltd. manufactures and distributes pharmaceutical products. It develops and commercializes an oral-based probiotic product for the treatment of mild to moderate Crohn's disease and ulcerative colitis and a novel family of protein, peptide therapeutics for the treatment of moderate to severe inflammatory bowel diseases. The company was founded by Denise Kelly in 2008 and is headquartered in Leeds, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| North West Seed Fund General Partner Ltd. | Director/Board Member | ||
| Aquarius Origin Fund Managing Member Ltd. | Director/Board Member | ||
Pulmagen Therapeutics LLP
 Pulmagen Therapeutics LLP Pharmaceuticals: MajorHealth Technology Pulmagen Therapeutics Ltd. manufactures and develops respiratory drugs. Its services include pulmagen respiratory product pipeline, pulmagen crth2 antagonist product pipeline, new generation bronchodilators-astrazeneca collaboration, theocort-inhaled corticosteroid re-sensitisation, inhaled ppar gamma agonists and chiesi collaboration-anti-inflammatory agents. The company was founded in February 2010 and is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
British Pharmacological Society
 British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Aquarius Equity Holdings Ltd.
 Aquarius Equity Holdings Ltd. Financial ConglomeratesFinance Aquarius Equity Holdings Ltd. functions as an investment holding British company. The private company is based in Manchester, UK. and has subsidiaries in United Kingdom. | Financial Conglomerates | Director/Board Member | |
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Biotechnology | Chairman | |
| Aquarius Northern Entrepreneurs Managing Member Ltd. | Director/Board Member | ||
Zogenix International Ltd.
 Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| 4D PHARMA PLC | Pharmaceuticals: Major | Founder | |
| Aquarius Equity Director Ltd. | Director/Board Member | ||
| Aquarius IV Fund Managing Member Ltd. | Director/Board Member | ||
| Aquarius Life Science Ltd. | Director/Board Member | ||
| Schosween 18 Ltd. | Director/Board Member | ||
The Microbiota Co. Ltd.
 The Microbiota Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of 4D Pharma Plc, The Microbiota Co. Ltd. develops a patented bacteria which treats irritable bowel syndrome and related symptoms. The company is based in Manchester, UK. The Microbiota Co. was acquired by 4D Pharma Plc on July 18, 2014 for $1.65 million. | Pharmaceuticals: Major | Director/Board Member | |
| Mbs Director Ltd. | Director/Board Member | ||
| Mbs Secretarial Ltd. | Director/Board Member | ||
Modern Biosciences Nominees Ltd.
 Modern Biosciences Nominees Ltd. Regional BanksFinance Modern Biosciences Nominees Ltd. acts as a nominee, trust, and depository. | Regional Banks | Director/Board Member | |
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Private Equity Investor | |
| UCL Medical School | College/University | Doctorate Degree | |
| Pimco 2664 Ltd. | Director/Board Member | ||
Microbiotica Ltd.
 Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman | |
Istesso Ltd.
 Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
Draupnir Bio ApS
 Draupnir Bio ApS Pharmaceuticals: MajorHealth Technology Draupnir Bio ApS engages in the manufacture and distribution of biotechnological and pharmaceutical products. It also provides medical research services. The company was founded on April 4, 2017 and is headquartered in Risskov, Denmark. | Pharmaceuticals: Major | Chairman | |
Maxion Therapeutics Ltd.
 Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman |
Statistics
International
| United Kingdom | 49 |
| Denmark | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 5 |
| Process Industries | 2 |
Operational
| Director/Board Member | 91 |
| Corporate Officer/Principal | 27 |
| Chairman | 23 |
| Chief Executive Officer | 14 |
| Director of Finance/CFO | 13 |
Most connected contacts
| Insiders | |
|---|---|
| Samuel Cameron Williams | 27 |
| Clive Dix | 24 |
| Mario Polywka | 21 |
| Alexander Stevenson | 19 |
| Piers John Morgan | 18 |
| Eva-Lotta Allan | 17 |
| Harry Finch | 15 |
| Simon Harford | 9 |
| Bradley Hoy | 7 |
| Natalie Walter | 7 |
| Craig Fox | 6 |
| Catherine Tralau-Stewart | 4 |
| Bhavna Hunjan | 2 |
| Nick Ray | 2 |
- Stock Market
- Insiders
- Emma Blaney
- Company connections